Почетна › Хронична лимфоцитна леукемија › Северна Каролина › Durham
Клинички испитувања за Хронична лимфоцитна леукемија во Durham, NC
27 студии за Хронична лимфоцитна леукемија бараат учесници на локации во и околу Durham (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Се регрутираФаза 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · на 10 милји
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- Durham VA Medical Center, Durham
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Се регрутираФаза 3
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · на 10 милји
- University of North Carolina-Hillsborough Campus, Hillsborough · на 13 милји
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Се регрутираФаза 3
- University of North Carolina At Chapel Hill, Chapel Hill · на 10 милји
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Се регрутираФаза 3
- Duke University Medical Center, Durham
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Се регрутираФаза 3
- Duke University Medical Center, Durham
- University of North Carolina At Chapel Hill, Chapel Hill · на 10 милји
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Се регрутираФаза 3
- Duke University, Durham
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Се регрутираФаза 2
- Duke University, Durham
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia
Се регрутираФаза 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · на 10 милји
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Се регрутираФаза 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · на 10 милји
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Се регрутираФаза 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · на 10 милји
Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
Се регрутираФаза 2
- Research Site, Durham
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
Се регрутираФаза 1
- University of North Carolina at Chapel Hill, Chapel Hill · на 10 милји
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Се регрутираФаза 1
- Duke University Medical Center, Durham
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Се регрутира
- North Carolina Basnight Cancer Hospital, Chapel Hill · на 10 милји
Registry of Older Patients With Cancer
Се регрутираНабљудувачка студија
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · на 10 милји
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Се регрутираФаза 1
- University of North Carolina, Chapel Hill · на 10 милји
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Се регрутираФаза 4
- Duke University Medical Center, Durham
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Се регрутираФаза 4
- Duke University Medical Center, Durham
Study of SGR-1505 in Mature B-Cell Neoplasms
Се регрутираФаза 1
- Duke University, Durham
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Се регрутираФаза 2
- University of North Carolina /ID# 233313, Chapel Hill · на 10 милји
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
Се регрутираФаза 2
- The University of North Carolina at Chapel Hill, Chapel Hill · на 10 милји
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Се регрутираФаза 1
- Duke University, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Се регрутираНабљудувачка студија
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · на 10 милји
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Се регрутираФаза 2
- Durham VA Medical Center, Durham, NC, Durham
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Се регрутираФаза 1
- University of North Carolina, Chapel Hill · на 10 милји
CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
Се регрутираФаза 1
- Duke University, Durham
Испитувања за Хронична лимфоцитна леукемија во други градови
- Boston, MA31 студија
- Columbus, OH28 студии
- Washington, DC22 студии
- Seattle, WA20 студии
- Rochester, MN19 студии
- New York City, NY18 студии
- Houston, TX17 студии
- Baldwin Park, CA16 студии
- Milwaukee, WI15 студии
- Chicago, IL14 студии
- Cincinnati, OH14 студии
- Nashville, TN13 студии
Други студии во Durham
- Рак на дојка63 студии
- Рак (сите типови)58 студии
- Рак на бели дробови со не-мали клетки39 студии
- Множен миелом37 студии
- Метастатски карцином33 студии
- Акутна миелоидна леукемија33 студии
- Рак на бели дробови32 студии
- Рак на простата32 студии
- Колоректален карцином28 студии
- Карцином на јајниците27 студии
- Срцева слабост26 студии
- Карцином на панкреасот24 студии
Од ClinicalTrials.gov, податоци преземени 5.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.